
News|Articles|May 1, 2004
- Pharmaceutical Technology-05-01-2004
- Volume 2004 Supplement
- Issue 3
Perspectives on Aseptic Guidance A Critical Review of FDA's 2003 Draft Guidance and a Proposed Alternative
Author(s)James P. Agalloco
FDA's draft guidance on aseptic processing contains some inherent difficulties, including unrealistic expectations of sterility and microbial quantification, an absence of harmonization with international rules, and failure to support new technologies or a risk-based approach. The authors propose a science-based alternative.
Advertisement
Articles in this issue
over 21 years ago
Implementing Total Organic Carbon Analysis for Cleaning Validationover 21 years ago
The Future of Aseptic Processing?An Updateover 21 years ago
Analysis of Environmental Microbiology Data from Cleanroom SamplesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
4
Targeted high resolution metabolite screening workflows
5





